ECG
ECG is an intervention with 72 clinical trials. Currently 10 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 36 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
7
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
36 of 45 finished
20.0%
9 ended early
10
trials recruiting
72
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Better Understanding of Fatigue After STroke
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Next Generation Personalized Neuroblastoma Therapy
Structured Review: To Optimise Management and Prevent Harm in COPD
Diagnosis of Postoperative Atrial Fibrillation by a Smartwatch
Clinical Trials (72)
Better Understanding of Fatigue After STroke
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Next Generation Personalized Neuroblastoma Therapy
Structured Review: To Optimise Management and Prevent Harm in COPD
Diagnosis of Postoperative Atrial Fibrillation by a Smartwatch
Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors
Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP)
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)
BMS-986253 in Myelodysplastic Syndromes
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Multicenter Cohort of STEMI Patients
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software
Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
Assessment of Venous Drainage in Idiopathic Intracranial Hypertension
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 72